Return to homepagePandemic Pact

ACTIV TRACE support at NCBI for SARS-CoV-2

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 75N97023F00096-0-0-2

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2023
    2028

  • Known Financial Commitments (USD)

    $2,354,179

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    KATHRYN FREELAND

  • Research Location

    United States of America

  • Lead Research Institution

    A-TEK, INC.

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen genomics, mutations and adaptations

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

To monitor and evaluate SARS-CoV-2 genome evolution and characterize representative variant viruses for their potential impact on medical countermeasures.